tiprankstipranks
Trending News
More News >
MariMed Inc (TSE:MRMD)
:MRMD
Canadian Market

MariMed (MRMD) Earnings Dates, Call Summary & Reports

Compare
4 Followers

Earnings Data

Report Date
Aug 19, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.01
Last Year’s EPS
>-0.01
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 07, 2025
|
% Change Since: -31.03%
|
Next Earnings Date:Aug 19, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with strong brand performance and strategic expansions offset by flat revenue growth, increased net loss, and retail revenue decline. The company's focus on wholesale growth and new product launches shows promise, but operational challenges remain.
Company Guidance
During MariMed Incorporated's First Quarter 2025 Financial Results Conference Call, the company provided several key metrics and strategic insights. Revenue for Q1 2025 was reported as flat year-over-year at $38 million, with a slight sequential decline of 2.7% due to seasonal impacts. The company's wholesale revenue grew by 16% year-over-year, now accounting for 44% of total revenue, up from 42% sequentially. Non-GAAP adjusted gross margin decreased to 41.3%, down from 43.8% the previous year, primarily due to price compression and increased costs from new facilities. MariMed reported a net loss of $5.4 million, compared to $1.3 million in the same period last year. Operating expenses rose to $16 million, partly due to a one-time receivable write-off. The company anticipates high single-digit revenue growth in Q2 2025 driven by wholesale expansion and promotional activities. They are also exploring new revenue sources, including a potential entry into the hemp market and the launch of new products like Microdose by Nature's Heritage, which leverages the growing trend of functional mushrooms.
Expansion in Storefronts
MariMed's brands were sold into 70 new storefronts during the quarter, contributing to an increase in wholesale revenue, which now accounts for 44% of the company's revenue mix, up from 42% sequentially.
Wholesale Growth
Wholesale gross revenue increased 16% compared to the prior year quarter and 4% sequentially, driven by increased market penetration.
Strong Brand Performance
In Illinois, the company's products were sold into more than 180 stores, representing a 5% increase sequentially and 46% year-on-year. Betty's, Vibations, and Bubby's brands performed well in multiple states, with Betty's climbing to number 5 in Illinois and maintaining the number 1 position in Massachusetts.
Community Support Initiatives
MariMed's Help on the Homefront program raised funds to assist veterans with housing costs, highlighting the company's commitment to community support.
New Product Launch
The introduction of Microdose by Nature's Heritage, a new product format focusing on functional mushrooms, was launched in Massachusetts and is expected to gain traction.
Strategic M&A and Licensing Opportunities
The acquisition of First State Compassion was completed, and MariMed is in discussions for licensing opportunities in new markets, which could expand brand distribution and market share.

MariMed (TSE:MRMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:MRMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 19, 2025
2025 (Q2)
-0.01 / -
-0.001
May 07, 2025
2025 (Q1)
-0.01 / -0.01
0
Mar 05, 2025
2024 (Q4)
-0.01 / -0.03
0.001-2100.00% (-0.03)
Nov 06, 2024
2024 (Q3)
-0.01 / <0.01
-0.014140.00% (+0.02)
Aug 07, 2024
2024 (Q2)
-0.01 / >-0.01
0.003-150.00% (>-0.01)
May 08, 2024
2024 (Q1)
-0.01 / 0.00
0.001
Mar 06, 2024
2023 (Q4)
0.00 / <0.01
0.014-90.00% (-0.01)
Nov 08, 2023
2023 (Q3)
>-0.01 / -0.01
0.014-200.00% (-0.03)
Aug 02, 2023
2023 (Q2)
0.00 / <0.01
0
May 08, 2023
2023 (Q1)
0.00 / <0.01
0.014-90.00% (-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:MRMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2025
C$0.14C$0.14-6.90%
Mar 05, 2025
C$0.17C$0.170.00%
Nov 06, 2024
C$0.21C$0.20-4.76%
Aug 07, 2024
C$0.23C$0.230.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does MariMed Inc (TSE:MRMD) report earnings?
MariMed Inc (TSE:MRMD) is schdueled to report earning on Aug 19, 2025, TBA Not Confirmed.
    What is MariMed Inc (TSE:MRMD) earnings time?
    MariMed Inc (TSE:MRMD) earnings time is at Aug 19, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:MRMD EPS forecast?
          TSE:MRMD EPS forecast for the fiscal quarter 2025 (Q2) is -0.01.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis